Metabolism and Nutrition Disorder Clinical Trial
Official title:
Study on the Regulatory Effects of Personalized Innovative Youtiao Intervention on Nutritional Health
The goal of this clinical trial is to investigate the effects of personalized innovative fritters on the nutritional health of overweight and obese individuals aged 40 to 70 years. The main questions it aims to answer are: - How does consuming personalized innovative fritters affect the nutritional health of overweight and obese individuals? - What is the mechanism underlying the impact of personalized innovative oil bars on nutritional health? Participants will be randomly assigned to one of two groups: a trial group consuming personalized innovative fritters and a control group consuming traditional fritters with equal energy content. Over the course of 6 months, participants will undergo two phases of intervention separated by a two-month washout period. During the intervention, participants will be assessed comprehensively for sensory ratings and nutritional health status through biological indicators, physical examinations, and other relevant measures. Researchers will compare the trial group to the control group to determine if personalized innovative fritters lead to improvements in nutritional health compared to traditional fritters.
Participants entered the trial with a 1-week equilibration period during which baked and fried foods were prohibited. The test group will consume personalised innovative Youtiao and the control group will uniformly consume traditional Youtiao of equal energy, 45 g 4 times per week for 8 weeks, during which time we will periodically measure biological indicators and collect biological samples to gain insight into the effects of the personalised innovative Youtiao on the participants. After completion of the 8-week intervention, a washout phase is entered. During this phase, participants will no longer ingest the Youtiao to see how they trend after stopping the intervention. Participants then enter the second phase of the trial, where the intervention process described above is continued with appropriate consumption adjustments based on the initial results of the first phase of the intervention. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05864833 -
METabolism After Orthopedic Surgery
|
||
| Completed |
NCT02235961 -
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT02918279 -
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
|
Phase 3 | |
| Completed |
NCT00978393 -
A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
|
Phase 1 | |
| Completed |
NCT03661879 -
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
|
Phase 1 | |
| Completed |
NCT05024032 -
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
|
Phase 3 | |
| Completed |
NCT02568306 -
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00781937 -
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
|
Phase 3 | |
| Completed |
NCT03223493 -
Awareness, Care & Treatment in Obesity Management (ACTION) Study
|
||
| Completed |
NCT03308721 -
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
|
Phase 1 | |
| Completed |
NCT02941042 -
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.
|
Phase 1 | |
| Completed |
NCT02453711 -
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
|
Phase 2 | |
| Completed |
NCT02527200 -
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
|
Phase 3 | |
| Completed |
NCT02958085 -
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
|
Phase 1 | |
| Terminated |
NCT00665665 -
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
|
Phase 1 | |
| Completed |
NCT04156165 -
The Effect of High vs. Moderate Protein Consumption on Human Health
|
N/A | |
| Recruiting |
NCT03669809 -
The Biological Rhythm of Human Metabolite
|
||
| Completed |
NCT02079870 -
Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
|
Phase 1 | |
| Completed |
NCT03095807 -
Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity
|
Phase 1 | |
| Recruiting |
NCT05785221 -
Lifestyle Intervention on Metabolic Homeostasis
|
N/A |